| Bioactivity | Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan is a drug-linker conjugate for ADC. Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan consists of Exatecan (HY-13631) and a linker. Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan can be used for synthesis of ADCs and for cancer research[1]. |
| Name | Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan |
| CAS | 1599439-54-9 |
| Formula | C57H65FN10O15 |
| Molar Mass | 1149.18 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, protect from light, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen) |
| Reference | [1]. Masuda Takeshi, et al. Preparation of antibody-drug conjugates for cancer therapy. Patent WO2014057687. |
Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan
CAS: 1599439-54-9 F: C57H65FN10O15 W: 1149.18
Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan is a drug-linker conjugate for ADC. Mal-PEG2-Gly-Gly-Phe-Gly-Exatecan consists of Exat
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.